ГОРМОНАЛЬНАЯ ТЕРАПИЯ С ИСПОЛЬЗОВАНИЕМ АГОНИСТОВ И АНТАГОНИСТОВ ЛЮТЕИНИЗИ- РУЮЩЕГО ГОРМОНА РЕЛИЗИНГ ГОРМОНА У БОЛЬНЫХ РАКОМ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ

К. М. Нюшко, А. А. Крашенинников, М. П. Головащенко et al. · Research and Practical Medicine Journal · 2015

Prostate cancer (PC) is one of the most actual problems of modern oncourology. Hormone therapy (HT) using medical castration is the main method of treatment of patients with metastatic PC. HT with usage of the new class of drugs that block the receptors for luteinizing hormone releasing hormone (LHRH) is a promising and effective method of castration therapy that has a number of significant advantages over the use of analogues LHRH. This article presents a review of studies that compared the effectiveness and side effects of HT using antagonists and analogues LHRH.

Cited by 0 works. doi:10.17709/2409-2231-2014-1-69-73

Authors

References